Citigroup’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $34.5K | Sell |
|
|||||
|
2025
Q2 | $218K | Sell |
|
|||||
|
2025
Q1 | $424K | Buy |
|
|||||
|
2024
Q4 | $818K | Buy |
|
|||||
|
2024
Q3 | $331K | Buy |
|
|||||
|
2024
Q2 | $150K | Buy |
|
|||||
|
2024
Q1 | $31.3K | Buy |
|
|||||
|
2023
Q4 | $18.2K | Sell |
|
|||||
|
2023
Q3 | $51.2K | Sell |
|
|||||
|
2023
Q2 | $1.43M | Sell |
|
|||||
|
2023
Q1 | $3.39M | Buy |
|
|||||
|
2022
Q4 | $2.47M | Sell |
|
|||||
|
2022
Q3 | $4.92M | Buy |
|
|||||
|
2022
Q2 | $4.64M | Buy |
|
|||||
|
2022
Q1 | $2.67M | Sell |
|
|||||
|
2021
Q4 | $5.93M | Buy |
|
|||||
|
2021
Q3 | $2.03M | Sell |
|
|||||
|
2021
Q2 | $6.4M | Buy |
|
|||||
|
2021
Q1 | $5.08M | Buy |
|
|||||
|
2020
Q4 | $2.56M | Buy |
|
|||||
|
2020
Q3 | $1.73M | Sell |
|
|||||
|
2020
Q2 | $8.88M | Buy |
|
|||||
|
2020
Q1 | $1.92M | Sell |
|
|||||
|
2019
Q4 | $1.81M | Sell |
|
|||||
|
2019
Q3 | $3.02M | Buy |
|
|||||
|
2019
Q2 | $2.16M | Buy |
|
|||||
|
2019
Q1 | $1.48M | Sell |
|
|||||
|
2018
Q4 | $3.61M | Buy |
|
|||||
|
2018
Q3 | $1.8M | Buy |
|
|||||
|
2018
Q2 | $380K | Sell |
|
|||||
|
2018
Q1 | $2.05M | Sell |
|
|||||
|
2017
Q4 | $2.2M | Sell |
|
|||||
|
2017
Q3 | $2.18M | Sell |
|
|||||
|
2017
Q2 | $2.07M | Buy |
|
|||||
|
2017
Q1 | $1.57M | Sell |
|
|||||
|
2016
Q4 | $3.8M | Buy |
|
|||||
|
2016
Q3 | $830K | Buy |
|
|||||
|
2016
Q2 | $290K | Sell |
|
|||||
|
2016
Q1 | $821K | Buy |
|
|||||
|
2015
Q4 | $104K | Sell |
|
|||||
|
2015
Q3 | $78K | Sell |
|
|||||
|
2015
Q2 | $95K | Sell |
|
|||||
|
2015
Q1 | $295K | Buy |
|
|||||
|
2014
Q4 | $42K | Sell |
|
|||||
|
2014
Q3 | $103K | Buy |
|
|||||
|
2014
Q2 | $108K | Buy |
|
|||||
|
2014
Q1 | $84K | Sell |
|
|||||
|
2013
Q4 | $232K | Buy |
|
|||||
|
2013
Q3 | $78K | Sell |
|
|||||
|
2013
Q2 | $143K | Buy |
|